Fierce Biotech

  1. Orgenesis inks Koligo buyout to gain COVID-19 cell therapy ntaylor Tue, 09/29/2020 - 08:18
  2. TriSalus hires Katz to run studies of ex-Dynavax cancer drug ntaylor Tue, 09/29/2020 - 07:42
  3. Killing cancer by blocking cell doors arlene.weintraub Tue, 09/29/2020 - 06:53
  4. Dewpoint Therapeutics to put 'pedal to the metal' with $77M round amysokolow2020 Mon, 09/28/2020 - 19:57
  5. South Korean exosome biotech Ilias Biologics nabs $20M B round badams Mon, 09/28/2020 - 08:32